TTD | Drug: D02SNO

Drug General Information
Drug ID	D02SNO
Former ID	DNC011817
Drug Name	2-Phenyl-3-(1-phenyl-ethoxy)-piperidine
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[551332]
Formula	C19H23NO
Canonical SMILES	CC(C1=CC=CC=C1)OC2CCCNC2C3=CC=CC=C3
InChI	1S/C19H23NO/c1-15(16-9-4-2-5-10-16)21-18-13-8-14-20-19(18)17-11-6-3-7-12-17/h2-7,9-12,15,18-20H,8,13-14H2,1H3/t15-,18+,19+/m1/s1
InChIKey	FFKDZHIKRMLWQT-MNEFBYGVSA-N
PubChem Compound ID	44331715
Target and Pathway
Target(s)	Substance-P receptor	Target Info	Inhibitor	[551332]
KEGG Pathway	Calcium signaling pathway
	Neuroactive ligand-receptor interaction
	Measles
PANTHER Pathway	CCKR signaling map ST
Reactome	G alpha (q) signalling events
WikiPathways	SIDS Susceptibility Pathways
	Gastrin-CREB signalling pathway via PKC and MAPK
	Spinal Cord Injury
	Peptide GPCRs
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 551332	3-Benzyloxy-2-phenylpiperidine NK1 antagonists: the influence of alpha methyl substitution, Bioorg. Med. Chem. Lett. 7(23):2959-2962 (1997).
Ref 551332	3-Benzyloxy-2-phenylpiperidine NK1 antagonists: the influence of alpha methyl substitution, Bioorg. Med. Chem. Lett. 7(23):2959-2962 (1997).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information